AVITA Medical (ASX:AVH) Announces New Manufacturing and Distribution Agreements
AVITA Medical (ASX:AVH) partners with Stedical Scientific to enhance production and distribution of PermeaDerm wound matrix.
AVITA Medical (ASX:AVH) partners with Stedical Scientific to enhance production and distribution of PermeaDerm wound matrix.
Navigator Global Investments Limited (ASX:NGI) acquires a 23.5% stake in healthcare investment firm 1315 Capital.
Global Health Limited (ASX:GLH) secures a $1 million contract with Youturn to enhance digital solutions for youth mental health services.
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.
Proteomics International (ASX:PIQ) launches PromarkerD, a predictive test for diabetic kidney disease, enhancing early diagnosis and intervention.
Telix Pharmaceuticals (ASX:TLX) completes acquisition of FAP-targeting theranostic candidates, expanding its oncology pipeline.
PolyNovo Limited (ASX:PNV) announces CEO transition with Dr Robyn Elliott appointed as Acting CEO as it seeks a permanent successor.
4DMedical Limited (ASX:4DX) secures a 3-year contract extension with Cleveland Clinic, ensuring continued revenue growth and expanding its presence in respiratory imaging.
Echo IQ (ASX:EIQ) announces an investor webinar to discuss its US commercialisation strategy and clinical pipeline.
333D Limited (ASX:T3D) appoints John Conidi as CEO, highlighting increased revenue and strategic investment in digital asset management.